|
Via F. Pelli 17 6900 Lugano |
| T.: +41 91 973 21 01 |
| F.: +41 91 973 21 06 |
| http://www.chemogroup.com |
| nicola.wicki@chemolugano.com |
| https://twitter.com/chemogroup |
| https://www.linkedin.com/company/chemo |
     
|
-
Main activities Licensing-In ● Licensing-Out ● Co-development ● Trading ● -
Drug stages Registration ● Market ● Generic Plus (505B2) ● Generic ● -
Therapeutic areas Cancer supportive therapy ● CNS ● Dermatology ● Gastrointestinal ● Gynaecology ● Ophtalmology ● Respiratory ● -
Markets CH ● EU Top 5 ● Rest of Europe ● USA and Canada ● LATAM ● MENA ● BRICS ● ASEAN ● Australia ● Japan ● -
Drug product forms Inhaler ● Oral (solid) ● Topical ● -
Drug substance type APIs (1-10kgs/batch) ● APIs (20-200kgs/batch) ● APIs (>200kgs/batch) ● HPAI 10-100g/batch ● HPAI 0.2-5kgs/batch ● HPAI 6-20kgs/batch ● HPAI >20kgs/batch ● Antibiotics ● Steroids ● -
Other activities (non pharma) Medical Devices ● Natural Products ● Nutraceuticals ●
|
Linkedin